SynthesisBMC cancer2024

Comparison of neoadjuvant single-agent treatment and dual-HER2 blockade for breast-conserving surgery conversion in HER2-positive breast cancer: a meta-analysis.

Manlu Cui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.